Hotchkis & Wiley Capital Management LLC Eli Lilly & CO Transaction History

Hotchkis & Wiley Capital Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $29,648 - $33,787	100 Added 2.13%	4,800 $1.55 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $585,333 - $687,267	-2,100 Reduced 30.88%	4,700 $1.52 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $70,407 - $87,498	-300 Reduced 4.23%	6,800 $1.95 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $449,700 - $558,080	-2,000 Reduced 21.98%	7,100 $1.96 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $131,456 - $170,176	-800 Reduced 8.08%	9,100 $1.7 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $39,138 - $51,789	-300 Reduced 2.94%	9,900 $1.67 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $263,196 - $304,434	-1,800 Reduced 15.0%	10,200 $1.51 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $155,106 - $181,048	-1,400 Reduced 10.45%	12,000 $1.33 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $100,179 - $117,918	-900 Reduced 6.29%	13,400 $1.74 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $667,170 - $747,432	-6,300 Reduced 30.58%	14,300 $1.66 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $206,064 - $257,544	-2,400 Reduced 10.43%	20,600 $2.21 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $143,830 - $165,072	-1,900 Reduced 7.63%	23,000 $1.96 Million
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $106,522 - $114,257	-1,300 Reduced 4.96%	24,900 $2.1 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $2.02 Million - $2.24 Million	26,200	26,200 $2.24 Million

4,121

740M

8.26M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $826B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Hotchkis & Wiley Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Hotchkis & Wiley Capital Management LLC with notifications on news.